… of novel antioxidants with anti-… of antioxidants with other agents, which have different
functions, will become the new strategies in protecting against neurodegenerative disorders. …

… of a neurodegenerative disease concomitantly show signs of oxidative stress. • Certain
neurodegenerative disorders … In some of these familial forms, mutations of antioxidant enzymes or …

… However, other types of antioxidants, … neurodegenerative contexts. This review highlights
the most relevant mitochondrial antioxidant targets in the main neurodegenerative disorders …

… free radical chemistry with respect to major neurodegenerative disorders viz. AD, PD, MS
and ALS. We report major antioxidant therapeutic target those are capable in neuroprotection …

… proposed use of antioxidant strategies to treat neurodegenerative diseases are considered.
… novel antioxidant and ROS scavengers, pharmaceutical compositions in which antioxidant …

… PD is the second most common neurodegenerative disorder after AD effecting about 1-2%
of people over 65 years old [3]. PD is characterised by a progressive loss of dopaminergic …

… antioxidants in the prevention and treatment of neurodegenerative disorders are discussed.
… in the pathology of several neurodegenerative disorders including Parkinson's disease (PD), …

… by using these nanomaterials for treatment of CNS disorders are outstanding. In this review
nanoantioxidants employed in various neurodegenerative diseases have been discussed. …

… altered metallostasis are both hallmarks of neurodegenerative disorders. However, it remains
… , among the strategies pursued to limit OS injury and the consequent neurodegeneration, …

… Monoamine aoxidase inhibitors (MAOIs) are currently used in the treatment of neurodegenerative
disorders such as AD. Thus, MAOIs prevent tau hyperphosphorylation, OS, and Aβ …